PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Word 1
Word 1 Count
CAT1
CAT2
Word 2
Word 2 Count
Co-occurrence
Occurence-Centile
Correlation
Overlap-Metric
G-Metric
CCL7 274 Target Target CCL3 1,427 51 0.08 -0.89 0.19 0.79
CCL7 274 Target Target CCL5 2,002 60 0.08 -0.87 0.22 0.79
DAPK2 27 Target Target DAPK1 205 6 0.08 -0.87 0.22 0.81
EPHA4 357 Target Target EPHA3 140 18 0.08 -0.91 0.13 0.82
ELC 355 Target Target Ck-beta-11 4 3 0.08 -0.50 0.75 0.78
Alpha-2a Adrenergic Receptor 188 Target Target Alpha-2c Adrenergic Receptor 42 7 0.08 -0.90 0.17 0.82
AACT 109 Target Target Alpha-1 AntiChymotrypsin 1,460 31 0.08 -0.84 0.28 0.78
Deep Vein Thrombosis 10,952 Disease Target D-Dimer 6,185 630 0.08 -0.92 0.10 0.77
CXCL10 2,386 Target Target CCL8 197 52 0.08 -0.85 0.26 0.77
Acute Coronary Syndromes 9,133 Disease Target Eptifibatide 772 200 0.08 -0.85 0.26 0.75
CCL7 274 Target Target CXCL2 750 34 0.08 -0.91 0.12 0.81
CD14 9,941 Target Target Endotoxin receptor 115 80 0.07 -0.55 0.70 0.74
Cytokeratin 8 587 Target Target Cytokeratin 18 1,108 60 0.07 -0.92 0.10 0.81
APOA1 958 Target Target APOA2 118 25 0.07 -0.88 0.21 0.79
CCL14 34 Target Target CCL8 197 6 0.07 -0.89 0.18 0.81
Thromboembolism 23,698 Disease Target D-Dimer 6,185 887 0.07 -0.91 0.14 0.75
CCL5 2,002 Target Target CXCL11 526 75 0.07 -0.91 0.14 0.79
C5a 4,164 Target Target C4A 1,177 161 0.07 -0.91 0.14 0.78
Epidermal Growth Factor Receptor 24,772 Target Target Erbb2 4,536 770 0.07 -0.90 0.17 0.74
CCL3 1,427 Target Target CCL8 197 38 0.07 -0.89 0.19 0.78
CCL5 2,002 Target Target CCL8 197 45 0.07 -0.87 0.23 0.78
ELC 355 Target Target Exodus-2 27 7 0.07 -0.85 0.26 0.79
CCL3 1,427 Target Target CCL1 220 39 0.07 -0.89 0.18 0.78
CCL7 274 Target Target CCL1 220 17 0.07 -0.93 0.08 0.82
CNTF 1,613 Target Target BDNF 11,163 292 0.07 -0.89 0.18 0.75
CNTF 1,613 Target Target Cardiotrophin-1 351 51 0.07 -0.91 0.15 0.78
Alpha-Glucosidase 4,319 Target Target Alpha-Amylase 7,171 376 0.07 -0.93 0.09 0.77
BD2 76 Target Target BD4 26 3 0.07 -0.92 0.12 0.82
EPHA4 357 Target Target EPHB2 385 25 0.07 -0.93 0.07 0.82
CAMK2A 42 Target Target CAMK2B 21 2 0.07 -0.93 0.10 0.83
Kadsurenone 70 Drug Target Platelet Activating Factor 9,915 56 0.07 -0.45 0.80 0.73
EPHA4 357 Target Target EPHA2 532 29 0.07 -0.93 0.08 0.81
CCL4 5,638 Target Target CCL2 3,560 295 0.07 -0.93 0.08 0.78
ACRP30 102 Target Target Adiponectin 11,994 72 0.07 -0.54 0.71 0.73
APOE 12,771 Target Target APOC1 126 82 0.06 -0.59 0.65 0.73
EGF 27,487 Target Target bFGF 9,327 1,029 0.06 -0.93 0.11 0.74
EPHA4 357 Target Target EPHB1 137 14 0.06 -0.93 0.10 0.81
CCL7 274 Target Target CXCL10 2,386 51 0.06 -0.89 0.19 0.77
CCL8 197 Target Target CXCL2 750 24 0.06 -0.92 0.12 0.79
CCL7 274 Target Target CCL14 34 6 0.06 -0.90 0.18 0.80
CCL2 3,560 Target Target CCL1 220 55 0.06 -0.86 0.25 0.76
CXCL10 2,386 Target Target CXCL2 750 83 0.06 -0.93 0.11 0.78
CD14 9,941 Target Target CD34 24,598 970 0.06 -0.93 0.10 0.74
EPHB4 329 Target Target EPHB1 137 13 0.06 -0.93 0.09 0.81
CEA 17,022 Target Target CA 72-4 184 108 0.06 -0.64 0.59 0.72
Beta-Glucosidase 4,297 Target Target Alpha-Glucosidase 4,319 261 0.06 -0.94 0.06 0.78
CCL5 2,002 Target Target CXCL2 750 73 0.06 -0.93 0.10 0.78
CEA 17,022 Target Target AFP 9,751 765 0.06 -0.94 0.08 0.75
CXCL3 145 Target Target CCL8 197 10 0.06 -0.94 0.07 0.82
CXCL7 76 Target Target CCL14 34 3 0.06 -0.94 0.09 0.82
Acute Coronary Syndromes 9,133 Disease Target Bivalirudin 891 167 0.06 -0.89 0.19 0.74
CCL2 3,560 Target Target CXCL10/IP-10 114 37 0.06 -0.82 0.32 0.75
CCL19 658 Target Target ELC 355 28 0.06 -0.94 0.08 0.80
AMAC-1 19 Target Target CCL18 256 4 0.06 -0.88 0.21 0.79
Epiregulin 291 Target Target EGF 27,487 162 0.06 -0.66 0.56 0.71
CXCL7 76 Target Target CCL8 197 7 0.06 -0.94 0.09 0.81
CCL5 2,002 Target Target CXCL10/IP-10 114 27 0.06 -0.87 0.24 0.76
EPHB3 118 Target Target EPHA3 140 7 0.05 -0.95 0.06 0.82
CXCL7 76 Target Target CXCL2 750 13 0.05 -0.90 0.17 0.78
Diabetes 332,602 Disease Target Adiponectin 11,994 3,433 0.05 -0.84 0.29 0.66
Epidermal Growth Factor Receptor 24,772 Target Target ERBB3 1,154 289 0.05 -0.86 0.25 0.72
Carcinoma 433,099 Disease Target AFP 9,751 3,499 0.05 -0.80 0.36 0.66
Leukemia 162,805 Disease Target CD34 24,598 3,403 0.05 -0.92 0.14 0.68
CCL18 256 Target Target CCL14 34 5 0.05 -0.91 0.15 0.79
Phospholipase A2 13,400 Target Target Platelet Activating Factor 9,915 614 0.05 -0.95 0.06 0.75
CCL2 3,560 Target Target CXCL3 145 38 0.05 -0.85 0.26 0.75
CCL8 197 Target Target CCL1 220 11 0.05 -0.95 0.06 0.81
CXCL11 526 Target Target CCL8 197 17 0.05 -0.94 0.09 0.79
Angiotensin-Converting Enzyme 2 665 Target Target Renin 43,456 283 0.05 -0.76 0.43 0.70
CD22 1,591 Target Target CD72 198 29 0.05 -0.92 0.15 0.77
Thromboembolism 23,698 Disease Target Antithrombin 13,773 929 0.05 -0.95 0.07 0.73
CCL5 2,002 Target Target CCL1 220 34 0.05 -0.91 0.15 0.76
CD68 6,424 Target Target CD14 9,941 408 0.05 -0.95 0.06 0.75
Ventricular Dysfunction 12,856 Disease Target BNP 6,842 477 0.05 -0.95 0.07 0.74
EPHB4 329 Target Target EPHA2 532 21 0.05 -0.95 0.06 0.80
CCL7 274 Target Target CXCL3 145 10 0.05 -0.95 0.07 0.80
Platelet Aggregation 25,460 Disease Target Platelet Activating Factor 9,915 783 0.05 -0.94 0.08 0.73
744.1 22 Target Target 464.1 19 1 0.05 -0.95 0.05 0.83
Cathepsin G 1,613 Target Target Alpha-1 AntiChymotrypsin 1,460 75 0.05 -0.95 0.05 0.78
CAMK2A 42 Target Target ADRBK1 10 1 0.05 -0.94 0.10 0.81
EPHA4 357 Target Target EPHB3 118 10 0.05 -0.94 0.08 0.79
Draflazine 33 Drug Target Equilibrative Nucleoside Transporter 1 211 4 0.05 -0.93 0.12 0.79
CXCL16 341 Target Target CXCL10 2,386 43 0.05 -0.93 0.13 0.76
EPHA2 532 Target Target EPHA3 140 13 0.05 -0.94 0.09 0.78
Adenosine A3 Receptor 164 Target Target Adenosine A1 Receptor 1,432 23 0.05 -0.92 0.14 0.76
Exodus-2 27 Target Target CCL21 808 7 0.05 -0.86 0.26 0.76
EPHA3 140 Target Target EPHB2 385 11 0.05 -0.95 0.08 0.79
CXCL9 1,016 Target Target CCL8 197 21 0.05 -0.94 0.11 0.77
Carcinoma 433,099 Disease Target CEA 17,022 4,013 0.05 -0.87 0.24 0.65
Epigen 27 Target Target beta-Cellulin 17 1 0.05 -0.95 0.06 0.83
CCL3 1,427 Target Target CXCL3 145 21 0.05 -0.92 0.14 0.76
Erbb2 4,536 Target Target EGF 27,487 513 0.05 -0.93 0.11 0.72
CCL7 274 Target Target CXCL9 1,016 24 0.05 -0.94 0.09 0.77
CCL19 658 Target Target CCL5 2,002 52 0.05 -0.95 0.08 0.77
ELC 355 Target Target DC-CK1 22 4 0.05 -0.90 0.18 0.77
A1M 59 Target Target B2M 677 9 0.05 -0.91 0.15 0.77
CCL4 5,638 Target Target CXCL10 2,386 165 0.04 -0.95 0.07 0.75
CD146 729 Target Target CD34 24,598 190 0.04 -0.86 0.26 0.71
Myeloperoxidase 16,181 Target Target Elastase 13,875 671 0.04 -0.96 0.05 0.74
CCL18 256 Target Target CCL3 1,427 27 0.04 -0.94 0.11 0.76